| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |